CYTO – altamira therapeutics ltd. - common shares (US:NASDAQ)

News

Altamira Therapeutics receives Nasdaq non-compliance letter [Seeking Alpha]
Altamira Therapeutics Provides Update on Nasdaq Listing
Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray
Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results
Nuance Pharma Announces Expansion of Bentrio License and Distribution Agreement with Altamira Therapeutics in East and South East Asia [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com